Fluorescence properties of methylene blue conjugated to normal/cancerous human tissues for spectral discrimination of breast cancer stages (I-IV)

Read full text Summarise with VIRAT
Authors: Romina Khoshnevisan, Parviz Parvin, Fatemeh Ramezani, Danial Noroozian, Nahid Nafissi, Parisa Mohammadi Matin, Ahmad Shariftabrizi, Fatemeh Atyabi, Somayeh Hashamdar
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Laser-induced fluorescence (LIF) spectroscopy is utilized to differentiate normal/malignant breast cells/tissues and classify cancer stages, using the biocompatible methylene blue (MB) fluorophore. Cancerous cells (MCF-7) conjugated with MB exhibit a red-shift of 3.96 ± 0.41 nm, corresponding to ~2.5 times higher signal intensity versus normal cells (MCF-10A). Regarding stages, tissue-level fluorescence intensity is elevated ~2.5 times in stage I and ~8 times in stage IV relative to healthy ones with red-shifts ranging from 3.73 ± 0.75 nm in stage I to 18.56 ± 2.15 nm in stage IV. Thus, LIF-MB technique offers a rapid, non-invasive method for both the early detection and grading of malignant tumors. The novelty of this work arises from the synergic contribution of the LIF and gravimetric validation for breast cancer staging.

Fields of Study & Subjects

Spectroscopy Techniques in Biomedical and Chemical Research Optical Imaging and Spectroscopy Techniques Photodynamic Therapy Research Studies

Publication details

Journal / source
Figshare
Publication date
30 March 2026
Language
EN